Lisette M. Acevedo

3.7k total citations · 1 hit paper
26 papers, 2.9k citations indexed

About

Lisette M. Acevedo is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lisette M. Acevedo has authored 26 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cell Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lisette M. Acevedo's work include Angiogenesis and VEGF in Cancer (5 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Lisette M. Acevedo is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Lisette M. Acevedo collaborates with scholars based in United States, United Kingdom and Germany. Lisette M. Acevedo's co-authors include David A. Cheresh, William C. Sessa, Eric A. Murphy, Sara M. Weis, David J. Shields, Lea Scheppke, Jean‐Philippe Gratton, R. Daniel Rudic, Giuseppe Cirino and Mariarosaria Bucci and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lisette M. Acevedo

25 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A role for VEGF as a negative regulator of pericyte function and vessel maturation

2008 501 citations Joshua I. Greenberg, David J. Shields et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisette M. Acevedo United States	17	1.9k	651	643	386	349	26	2.9k
Joanne Bruno United States	11	2.0k 1.1×	403 0.6×	451 0.7×	483 1.3×	343 1.0×	12	3.1k
Ivo Cornelissen United States	21	1.8k 1.0×	446 0.7×	411 0.6×	386 1.0×	389 1.1×	28	3.0k
Graciela B. Sala‐Newby United Kingdom	30	1.5k 0.8×	316 0.5×	622 1.0×	207 0.5×	282 0.8×	61	2.6k
Akiyoshi Uemura Japan	29	2.1k 1.1×	461 0.7×	377 0.6×	177 0.5×	398 1.1×	70	3.5k
Sergio Caballero United States	38	2.4k 1.3×	315 0.5×	555 0.9×	302 0.8×	411 1.2×	99	4.5k
Kip M. Connor United States	32	2.3k 1.3×	460 0.7×	534 0.8×	300 0.8×	209 0.6×	53	4.9k
Lingfang Zeng United Kingdom	37	2.2k 1.2×	672 1.0×	604 0.9×	277 0.7×	275 0.8×	75	3.7k
Karin Strittmatter Switzerland	16	1.3k 0.7×	304 0.5×	426 0.7×	345 0.9×	792 2.3×	20	3.3k
Kevin Pumiglia United States	30	2.2k 1.2×	689 1.1×	637 1.0×	219 0.6×	758 2.2×	43	4.0k
Andrew C. Dudley United States	33	1.8k 1.0×	322 0.5×	914 1.4×	291 0.8×	662 1.9×	60	3.2k

Countries citing papers authored by Lisette M. Acevedo

Since Specialization

Citations

This map shows the geographic impact of Lisette M. Acevedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisette M. Acevedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisette M. Acevedo more than expected).

Fields of papers citing papers by Lisette M. Acevedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisette M. Acevedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisette M. Acevedo. The network helps show where Lisette M. Acevedo may publish in the future.

Co-authorship network of co-authors of Lisette M. Acevedo

This figure shows the co-authorship network connecting the top 25 collaborators of Lisette M. Acevedo. A scholar is included among the top collaborators of Lisette M. Acevedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisette M. Acevedo. Lisette M. Acevedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koreth, John, Jeremy Pantin, Shukaib Arslan, et al.. (2025). Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.. Blood. 146(Supplement 1). 274–274.

Koreth, John, Edmund K. Waller, Ryotaro Nakamura, et al.. (2022). Updated Interim Results from the Equate Study: Preliminary Safety and Efficacy of Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Acute Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 28(3). S288–S288. 1 indexed citations

Koreth, John, Jerome Ritz, Leslie W. Chinn, et al.. (2021). Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease. Blood. 138(Supplement 1). 2891–2891. 2 indexed citations

Acevedo, Lisette M., Paramdeep Baweja, Kye Gilder, et al.. (2020). P396 Pharmacokinetics and circulating total lymphocyte count pharmacodynamic response from single and multiple oral doses of etrasimod in Japanese and Caucasian healthy male subjects. Journal of Crohn s and Colitis. 14(Supplement_1). S368–S368. 4 indexed citations

Pi‐Sunyer, F. Xavier, Caroline M. Apovian, Susan L. McElroy, et al.. (2019). Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis. International Journal of Obesity. 43(10). 2085–2094. 19 indexed citations

Halseth, Amy E., et al.. (2018). Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion. Obesity Science & Practice. 4(2). 141–152. 22 indexed citations

Tiessen, Renger G., Ciara Kennedy, Bradley T. Keller, et al.. (2018). Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. BMC Gastroenterology. 18(1). 3–3. 45 indexed citations

Acevedo, Lisette M., Jeffrey N. Lindquist, Flavio Cimadamore, et al.. (2015). hESC Differentiation toward an Autonomic Neuronal Cell Fate Depends on Distinct Cues from the Co-Patterning Vasculature. Stem Cell Reports. 4(6). 1075–1088. 16 indexed citations

Chen, Xiao Lei, Ju‐Ock Nam, Christine Jean, et al.. (2012). VEGF-Induced Vascular Permeability Is Mediated by FAK. Developmental Cell. 22(1). 146–157. 268 indexed citations

10.

Murphy, Eric A., Bharat K. Majeti, Rajesh Mukthavaram, et al.. (2011). Targeted Nanogels: A Versatile Platform for Drug Delivery to Tumors. Molecular Cancer Therapeutics. 10(6). 972–982. 62 indexed citations

11.

Anand, Sudarshan, Bharat K. Majeti, Lisette M. Acevedo, et al.. (2010). MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16(8). 909–914. 418 indexed citations

12.

Datto, Catherine, A. Nordenhem, Margaret Minkwitz, et al.. (2009). Effectiveness of Extended-release Formulation of Quetiapine as Monotherapy for the Treatment of Acute Bipolar Mania (Trial D144CC00004). European Psychiatry. 24(S1). 5 indexed citations

13.

Greenberg, Joshua I., David J. Shields, Lisette M. Acevedo, et al.. (2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 456(7223). 809–813. 501 indexed citations breakdown →

14.

Doukas, John, Karin J. Stebbins, Luis Dellamary, et al.. (2008). Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease. Journal of Pharmacology and Experimental Therapeutics. 328(3). 758–765. 86 indexed citations

15.

Schleicher, Michael, Benjamin R. Shepherd, Yajaira Suárez, et al.. (2008). Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. The Journal of Cell Biology. 180(1). 101–112. 168 indexed citations

16.

Bernatchez, Pascal, Lisette M. Acevedo, Carlos Fernández‐Hernando, et al.. (2007). Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function. Journal of Biological Chemistry. 282(42). 30745–30753. 95 indexed citations

17.

Alavi, Alireza, Lisette M. Acevedo, Min Wang, & David A. Cheresh. (2007). Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1–Mediated Inhibition of the Proapoptotic Kinase, ASK1. Cancer Research. 67(6). 2766–2772. 72 indexed citations

18.

Fulton, David, Roger W. Babbitt, Jason Fontana, et al.. (2004). Targeting of Endothelial Nitric-oxide Synthase to the Cytoplasmic Face of the Golgi Complex or Plasma Membrane Regulates Akt- Versus Calcium-dependent Mechanisms for Nitric Oxide Release. Journal of Biological Chemistry. 279(29). 30349–30357. 112 indexed citations

19.

Acevedo, Lisette M., Jun Yu, Hediye Erdjument‐Bromage, et al.. (2004). A new role for Nogo as a regulator of vascular remodeling. Nature Medicine. 10(4). 382–388. 207 indexed citations

20.

Bucci, Mariarosaria, Jean‐Philippe Gratton, R. Daniel Rudic, et al.. (2000). In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nature Medicine. 6(12). 1362–1367. 467 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact